Knowing that KIF2C is important in the relapse of ALL and for the maintenance of HSCs in zebrafish, we propose that KIF2C can be a novel therapeutic target for relapsed ALL. The gene discussed is KIF2C; the disease is acute lymphoblastic leukemia.